Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Gastrointestinal 2

Conditions

Neoplasms 8Breast Neoplasms 6Malnutrition 5Stomach Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Lymphoma 2Locally Advanced Head and Neck Carcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Cachexia 2Biliary Tract Neoplasms 2Wilms Tumor 1Surgery--Complications 1Sarcoma 1Prostatic Intraepithelial Neoplasia 1Peripheral Nervous System Diseases 1Peptic Ulcer 1Osteoporosis 1Nutrition Related Cancer 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Breast Neoplasms × Dietary Supplements × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT07021378 2025-06-15

NESTLE

D'Or Institute for Research and Education

Phase NA Completed
16 enrolled
BreastGastrointestinal

Anus Neoplasms, Breast Neoplasms, Malnutrition

NCT06214598 2024-05-09

AID

University of Belgrade

Phase NA Recruiting
90 enrolled
Breast

Breast Neoplasms

NCT05762042 2023-03-09

Comparison of the Efficacy and Tolerability of Femal Versus Placebo

Azienda Ospedaliera Ordine Mauriziano di Torino

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

NCT01548534 2015-07-29

DHALYA

University Hospital, Tours

Phase 3 Terminated
65 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡